Transition Day In The US: 96 Drugs Make The Move To Biologics Regulation

 
• By Sue Sutter
Open wooden door to the new world with green environment. Climate change concept.
US FDA’s door is now open to applications for biosimilar and interchangeable insulins. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics